Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4WML
|
||||
| Drug Name |
2-methyl-5-(2-(4-((3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)methyl)piperidin-1-yl)ethoxy)quinoline-7-carbonitrile
|
||||
| Synonyms |
CHEMBL239167
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H28N4O3
|
||||
| Canonical SMILES |
Cc1ccc2c(OCCN3CCC(Cc4ccc5OCC(=O)Nc5c4)CC3)cc(cc2n1)C#N
|
||||
| InChI |
InChI=1S/C27H28N4O3/c1-18-2-4-22-23(29-18)14-21(16-28)15-26(22)33-11-10-31-8-6-19(7-9-31)12-20-3-5-25-24(13-20)30-27(32)17-34-25/h2-5,13-15,19H,6-12,17H2,1H3,(H,30,32)
|
||||
| InChIKey |
LPJXWMSBQMJCDG-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.